Core Viewpoint - Meili Tianyuan Medical Health (02373) demonstrates strong confidence in its future development through share buybacks and insider purchases, indicating a belief that current share prices do not reflect the company's intrinsic value [1] Group 1: Insider Transactions - Non-executive director Ms. Yi Lin purchased a total of 61,000 shares in the open market using personal funds on October 24, 2025, reflecting a strong belief in the company's future prospects [1] Group 2: Share Buyback Activity - On October 30, 2025, the company repurchased 30,000 shares at a total transaction amount of approximately HKD 927,150, with an average price of about HKD 30.91 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 475,000 shares for a total consideration of approximately HKD 15,069,220 [1] Group 3: Management's Perspective - The board believes that the current trading price of the shares does not reflect their intrinsic value and the actual business prospects of the company [1] - The board asserts that the share buyback reflects management's strong confidence in the long-term value of the enterprise, which is beneficial for enhancing the company's market value and shareholder return capabilities [1]
美丽田园医疗健康获非执行董事易琳增持6.1万股